Ligand validation:6B60

GLU: GLUTAMIC ACID

GLU is a Ligand Of Interest in 6B60 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6B60_GLU_A_506	49%	34%	0.151	0.899	1.14	1.44	-	2	2	0	100%	1
6B60_GLU_B_302	32%	39%	0.215	0.89	1.07	1.32	-	2	0	0	100%	1
6B60_GLU_B_301	30%	35%	0.189	0.853	0.89	1.63	-	2	2	0	100%	1
6B60_GLU_A_501	9%	30%	0.259	0.756	1.26	1.52	1	2	0	0	100%	1
6B62_GLU_B_301	46%	19%	0.12	0.855	2.06	1.43	3	2	3	0	100%	1
6B66_GLU_A_501	28%	43%	0.198	0.852	1.08	1.12	-	2	1	0	100%	1
6R85_GLU_B_301	100%	38%	0.025	0.991	1.06	1.34	-	2	0	0	100%	1
8U79_GLU_A_401	100%	54%	0.025	0.994	0.96	0.82	-	-	0	0	100%	1
2VHA_GLU_B_1280	100%	22%	0.031	0.988	1.94	1.3	2	1	0	0	100%	1
8R32_GLU_A_901	100%	45%	0.031	0.986	1.03	1.11	-	1	0	0	100%	1
3RWN_GLU_C_1	100%	50%	0.04	0.994	0.99	0.94	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.